BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 30471427)

  • 1. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
    Tonello R; Lee SH; Berta T
    J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
    Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
    J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
    Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
    J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
    Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
    J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
    Singhmar P; Huo X; Li Y; Dougherty PM; Mei F; Cheng X; Heijnen CJ; Kavelaars A
    Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
    Krukowski K; Nijboer CH; Huo X; Kavelaars A; Heijnen CJ
    Pain; 2015 Nov; 156(11):2184-2192. PubMed ID: 26473292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
    Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
    J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats.
    Ledeboer A; Jekich BM; Sloane EM; Mahoney JH; Langer SJ; Milligan ED; Martin D; Maier SF; Johnson KW; Leinwand LA; Chavez RA; Watkins LR
    Brain Behav Immun; 2007 Jul; 21(5):686-98. PubMed ID: 17174526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
    Chine VB; Au NPB; Kumar G; Ma CHE
    Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible co-stimulatory molecule (ICOS) alleviates paclitaxel-induced neuropathic pain via an IL-10-mediated mechanism in female mice.
    Sankaranarayanan I; Tavares-Ferreira D; Mwirigi JM; Mejia GL; Burton MD; Price TJ
    J Neuroinflammation; 2023 Feb; 20(1):32. PubMed ID: 36774519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.
    Kyte SL; Toma W; Bagdas D; Meade JA; Schurman LD; Lichtman AH; Chen ZJ; Del Fabbro E; Fang X; Bigbee JW; Damaj MI; Gewirtz DA
    J Pharmacol Exp Ther; 2018 Jan; 364(1):110-119. PubMed ID: 29042416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms.
    Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG
    PLoS One; 2013; 8(11):e80915. PubMed ID: 24260511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.
    Zhang H; Boyette-Davis JA; Kosturakis AK; Li Y; Yoon SY; Walters ET; Dougherty PM
    J Pain; 2013 Oct; 14(10):1031-44. PubMed ID: 23726937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions targeting Wnt/β-catenin signaling pathway attenuate paclitaxel-induced peripheral neuropathy.
    Resham K; Sharma SS
    Eur J Pharmacol; 2019 Dec; 864():172714. PubMed ID: 31586636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy.
    Gu H; Wang C; Li J; Yang Y; Sun W; Jiang C; Li Y; Ni M; Liu WT; Cheng Z; Hu L
    Int J Cancer; 2020 May; 146(10):2810-2821. PubMed ID: 31465111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan, an Angiotensin II Type 1 Receptor Antagonist, Alleviates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain by Inhibiting Inflammatory Cytokines in the Dorsal Root Ganglia.
    Kim E; Hwang SH; Kim HK; Abdi S; Kim HK
    Mol Neurobiol; 2019 Nov; 56(11):7408-7419. PubMed ID: 31037647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
    Kume M; Ahmad A; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
    J Pain; 2023 Nov; 24(11):1980-1993. PubMed ID: 37315729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers.
    Ma J; Trinh RT; Mahant ID; Peng B; Matthias P; Heijnen CJ; Kavelaars A
    Pain; 2019 Dec; 160(12):2877-2890. PubMed ID: 31356453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Complement in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy.
    Xu J; Zhang L; Xie M; Li Y; Huang P; Saunders TL; Fox DA; Rosenquist R; Lin F
    J Immunol; 2018 Jun; 200(12):4094-4101. PubMed ID: 29695418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation.
    Koyanagi M; Imai S; Iwamitsu Y; Matsumoto M; Saigo M; Moriya A; Ogihara T; Nakazato Y; Yonezawa A; Nakagawa S; Nakagawa T; Matsubara K
    Neuropharmacology; 2021 May; 188():108514. PubMed ID: 33684416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.